{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:54:22Z","timestamp":1786982062033,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P50 CA0972474"],"award-info":[{"award-number":["P50 CA0972474"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11764-019-00846-x","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T02:02:53Z","timestamp":1577930573000},"page":"316-321","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Compliance with cancer screening and influenza vaccination guidelines in non-Hodgkin lymphoma survivors"],"prefix":"10.1007","volume":"14","author":[{"given":"Priyanka A.","family":"Pophali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa C.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristine","family":"Allmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umar","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Cerhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4518-2309","authenticated-orcid":false,"given":"Carrie A.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,2]]},"reference":[{"key":"846_CR1","unstructured":"Howlader N NA, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). . SEER Cancer Statistics Review, 1975\u20132016 National Cancer Institute. Bethesda, MD2019 [based on November 2018 SEER data submission, posted to the SEER web site, April 9.]. Available from: https:\/\/seer.cancer.gov\/csr\/1975_2016\/,."},{"issue":"4","key":"846_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3322\/caac.21349","volume":"66","author":"KD Miller","year":"2016","unstructured":"Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271\u201389.","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"846_CR3","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2015.4862","volume":"313","author":"D Blumenthal","year":"2015","unstructured":"Blumenthal D, McGinnis JM. Measuring vital signs an IOM report on core metrics for health and health care progress. Jama-J Am Med Assoc. 2015;313(19):1901\u20132.","journal-title":"Jama-J Am Med Assoc"},{"issue":"5","key":"846_CR4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/bjh.12684","volume":"164","author":"J Lorenzo Bermejo","year":"2014","unstructured":"Lorenzo Bermejo J, Pukkala E, Johannesen TB, Sundquist J, Hemminki K. Age-time risk patterns of solid cancers in 60 901 non-Hodgkin lymphoma survivors from Finland, Norway and Sweden. Br J Haematol. 2014;164(5):675\u201383.","journal-title":"Br J Haematol"},{"issue":"14","key":"846_CR5","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1200\/JCO.2016.70.9709","volume":"35","author":"A Sud","year":"2017","unstructured":"Sud A, Thomsen H, Sundquist K, Houlston RS, Hemminki K. Risk of second cancer in Hodgkin lymphoma survivors and influence of family history. J Clin Oncol. 2017;35(14):1584\u201390.","journal-title":"J Clin Oncol"},{"issue":"10","key":"846_CR6","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1200\/JCO.2005.04.2200","volume":"24","author":"NY Mudie","year":"2006","unstructured":"Mudie NY, Swerdlow AJ, Higgins CD, Smith P, Qiao Z, Hancock BW, et al. Risk of second malignancy after non-Hodgkin\u2019s lymphoma: a British cohort study. J Clin Oncol. 2006;24(10):1568\u201374.","journal-title":"J Clin Oncol"},{"issue":"10","key":"846_CR7","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.3109\/10428194.2015.1007505","volume":"56","author":"C Rossi","year":"2015","unstructured":"Rossi C, Jegu J, Mounier M, Dandoit M, Colonna M, Daubisse-Marliac L, et al. Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma. Leuk Lymphoma. 2015;56(10):2876\u201382.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"846_CR8","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1080\/10428190902756578","volume":"50","author":"T Seshadri","year":"2009","unstructured":"Seshadri T, Pintilie M, Kuruvilla J, Keating A, Tsang R, Zadeh S, et al. Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma. Leuk Lymphoma. 2009;50(3):380\u20136.","journal-title":"Leuk Lymphoma."},{"issue":"23","key":"846_CR9","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1182\/blood-2014-05-579193","volume":"124","author":"AK Ng","year":"2014","unstructured":"Ng AK. Current survivorship recommendations for patients with Hodgkin lymphoma: focus on late effects. Blood. 2014;124(23):3373\u20139.","journal-title":"Blood."},{"key":"846_CR10","doi-asserted-by":"crossref","unstructured":"Uhlig A, Mei J, Baik I, Meyer C, Uhlig J. Screening utilization among cancer survivors: a meta-analysis. J Public Health (Oxf). 2017:1\u20139.","DOI":"10.1093\/pubmed\/fdx030"},{"issue":"6","key":"846_CR11","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1093\/ije\/dyx119","volume":"46","author":"James R Cerhan","year":"2017","unstructured":"Cerhan JR, Link BK, Habermann TM, Maurer MJ, Feldman AL, Syrbu SI, et al. Cohort profile: the Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) cohort study. Int J Epidemiol. 2017;46(6):1753-4i.","journal-title":"International Journal of Epidemiology"},{"key":"846_CR12","unstructured":"Centers for Disease Control and Prevention. Sortable risk factors and health indicators website, last updated (6\/11\/2018). [Available from: http:\/\/sortablestats.cdc.gov\/."},{"key":"846_CR13","unstructured":"National Center for Health Statistics. Health, United States, 2017: With special feature on mortality. . Hyattsville, Maryland 2018."},{"key":"846_CR14","unstructured":"Society. AC. Cancer prevention & early detection facts & figures 2010. Atlanta: American Cancer Society; [."},{"issue":"10","key":"846_CR15","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1200\/JCO.2013.51.5866","volume":"32","author":"MJ Maurer","year":"2014","unstructured":"Maurer MJ, Ghesquieres H, Jais JP, Witzig TE, Haioun C, Thompson CA, et al. Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy. J Clin Oncol. 2014;32(10):1066\u201373.","journal-title":"J Clin Oncol"},{"issue":"14","key":"846_CR16","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1200\/JCO.2009.26.6908","volume":"28","author":"DA Pollyea","year":"2010","unstructured":"Pollyea DA, Brown JM, Horning SJ. Utility of influenza vaccination for oncology patients. J Clin Oncol. 2010;28(14):2481\u201390.","journal-title":"J Clin Oncol"},{"issue":"3","key":"846_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/cid\/cit816","volume":"58","author":"LG Rubin","year":"2014","unstructured":"Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):309\u201318.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"846_CR18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10875-007-9073-3","volume":"27","author":"P Centkowski","year":"2007","unstructured":"Centkowski P, Brydak L, Machala M, Kalinka-Warzocha E, Blasinska-Morawiec M, Federowicz I, et al. Immunogenicity of influenza vaccination in patients with non-Hodgkin lymphoma. J Clin Immunol. 2007;27(3):339\u201346.","journal-title":"J Clin Immunol"},{"issue":"3","key":"846_CR19","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/cncr.21203","volume":"104","author":"CD Cooksley","year":"2005","unstructured":"Cooksley CD, Avritscher EB, Bekele BN, Rolston KV, Geraci JM, Elting LS. Epidemiology and outcomes of serious influenza-related infections in the cancer population. Cancer. 2005;104(3):618\u201328.","journal-title":"Cancer."},{"key":"846_CR20","doi-asserted-by":"crossref","unstructured":"Blanchette PS, Chung H, Pritchard KI, Earle CC, Campitelli MA, Buchan SA, et al. Influenza vaccine effectiveness among patients with cancer: a population-based study using health administrative and laboratory testing data from Ontario, Canada. J Clin Oncol. 2019:JCO1900354.","DOI":"10.1093\/annonc\/mdy297.021"},{"issue":"1","key":"846_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1370\/afm.26","volume":"2","author":"KC Oeffinger","year":"2004","unstructured":"Oeffinger KC, Mertens AC, Hudson MM, Gurney JG, Casillas J, Chen H, et al. Health care of young adult survivors of childhood cancer: a report from the Childhood Cancer Survivor study. Ann Fam Med. 2004;2(1):61\u201370.","journal-title":"Ann Fam Med"},{"issue":"6","key":"846_CR22","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1172\/JCI108415","volume":"57","author":"GW King","year":"1976","unstructured":"King GW, Yanes B, Hurtubise PE, Balcerzak SP, LoBuglio AF. Immune function of successfully treated lymphoma patients. J Clin Invest. 1976;57(6):1451\u201360.","journal-title":"J Clin Invest"},{"issue":"2","key":"846_CR23","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/annonc\/mdl399","volume":"18","author":"G Sanna","year":"2007","unstructured":"Sanna G, Lorizzo K, Rotmensz N, Bagnardi V, Cinieri S, Colleoni M, et al. Breast cancer in Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma survivors. Ann Oncol. 2007;18(2):288\u201392.","journal-title":"Ann Oncol"},{"issue":"8","key":"846_CR24","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1093\/annonc\/mdq697","volume":"22","author":"M Pirani","year":"2011","unstructured":"Pirani M, Marcheselli R, Marcheselli L, Bari A, Federico M, Sacchi S. Risk for second malignancies in non-Hodgkin\u2019s lymphoma survivors: a meta-analysis. Ann Oncol. 2011;22(8):1845\u201358.","journal-title":"Ann Oncol"},{"issue":"11","key":"846_CR25","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s00432-015-1979-1","volume":"141","author":"SH Chien","year":"2015","unstructured":"Chien SH, Liu CJ, Hong YC, Teng CJ, Hu YW, Ku FC, et al. Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study. J Cancer Res Clin Oncol. 2015;141(11):1995\u20132004.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"18","key":"846_CR26","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1200\/JCO.2012.46.5732","volume":"31","author":"AK Ng","year":"2013","unstructured":"Ng AK, Garber JE, Diller LR, Birdwell RL, Feng Y, Neuberg DS, et al. Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma. J Clin Oncol. 2013;31(18):2282\u20138.","journal-title":"J Clin Oncol"},{"issue":"6","key":"846_CR27","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s00520-013-2113-z","volume":"22","author":"LP Forsythe","year":"2014","unstructured":"Forsythe LP, Arora NK, Alfano CM, Weaver KE, Hamilton AS, Aziz N, et al. Role of oncologists and primary care physicians in providing follow-up care to non-Hodgkin lymphoma survivors within 5 years of diagnosis: a population-based study. Support Care Cancer. 2014;22(6):1509\u201317.","journal-title":"Support Care Cancer"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-019-00846-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11764-019-00846-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-019-00846-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T20:00:31Z","timestamp":1609444831000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11764-019-00846-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,2]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["846"],"URL":"https:\/\/doi.org\/10.1007\/s11764-019-00846-x","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,2]]},"assertion":[{"value":"12 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}